跳转至内容
Merck
CN

G5918

GR 113808

≥98% (HPLC), solid

别名:

1-[2-[(甲磺酰基)氨基]乙基]-4-哌啶基]甲基1-甲基-1H-吲哚-3-羧酸酯

登录 查看公司和协议定价

选择尺寸


关于此项目

经验公式(希尔记法):
C19H27N3O4S
化学文摘社编号:
分子量:
393.50
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:
NACRES:
NA.77
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

质量水平

方案

≥98% (HPLC)

表单

solid

颜色

white to light pink

溶解性

DMSO: >20 mg/mL

创始人

GlaxoSmithKline

储存温度

2-8°C

SMILES字符串

Cn1cc(C(=O)OCC2CCN(CCNS(C)(=O)=O)CC2)c3ccccc13

InChI

1S/C19H27N3O4S/c1-21-13-17(16-5-3-4-6-18(16)21)19(23)26-14-15-7-10-22(11-8-15)12-9-20-27(2,24)25/h3-6,13,15,20H,7-12,14H2,1-2H3

InChI key

MOZPSIXKYJUTKI-UHFFFAOYSA-N

基因信息

human ... HTR4(3360)
rat ... Htr3a(79246), Htr4(25324)

应用

GR 113808已被用作5-羟色胺受体4(5-HT4R)阻断剂,以研究其对大鼠心室心肌细胞中钙(Ca2+)瞬变的影响。它也已被用作5-HT4R拮抗剂,以研究其对胚胎后斑马鱼从头肠神经发生的影响。

生化/生理作用

GR 113808是5-HT4血清素受体拮抗剂。

特点和优势

该化合物由 GlaxoSmithKline开发。想浏览其他制药公司开发的化合物和已批准药物/候选药物目录, 请单击此处

法律信息

根据Glaxo­Smith­Kline的协议出售用于研究目的

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, type N95 (US)


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

I Gribovskaja-Rupp et al.
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society, 24(5), 472-478 (2012-02-07)
Colonic dysfunction occurs after pelvic autonomic nerve damage. The enteric nervous system can compensate. We investigated the role of mucosal serotonin receptors, 5-HT(3) and 5-HT(4) , in the colonic motility restoration over 2 weeks after parasympathetic pelvic nerve transection in
Kurt A Krobert et al.
Naunyn-Schmiedeberg's archives of pharmacology, 371(6), 473-479 (2005-07-14)
Prucalopride is a gastrointestinal prokinetic drug that acts through 5-HT4 receptors, but its potential effects on cardiac atrial function are unknown. We investigated the effects of prucalopride on human right atrium, piglet left atrium, and piglet sinoatrial node. The effects
M Cachard-Chastel et al.
British journal of pharmacology, 150(7), 883-892 (2007-02-28)
A strategy to treat Alzheimer's disease (AD) is to increase the soluble form of amyloid precursor protein (sAPPalpha), a promnesic protein, in the brain. Because strong evidence supports beneficial effects of 5-hydroxytryptamine 5-HT(4) receptor agonists in memory and learning, we
H Matsuyoshi et al.
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society, 22(7), 806-813 (2010-02-12)
It was recently reported that some 5-HT(4)-receptor agonists increased neuronal numbers and length of neurites in enteric neurons developing in vitro from immunoselected neural crest-derived precursors. We aimed to explore a novel approach in vivo to reconstruct the enteric neural
J P Spencer et al.
Neuroscience, 129(1), 49-54 (2004-10-19)
5-HT(4) receptors are widely distributed in both peripheral and central nervous systems where they couple, via a G-protein, to the activation of adenylate cyclase. In the brain, the highest 5-HT(4) receptor densities are found in the limbic system, including the

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持